Clinical trial / 2014
In patients with type 2 diabetes, erythritol acutely improved endothelial function and chronically reduced central pulse pressure.
A pilot study evaluated the vascular effects of erythritol in 24 patients with type 2 diabetes mellitus who consumed 36 g/day of erythritol for 4 weeks alongside a single 24 g dose at baseline and final visits. Acute erythritol intake improved endothelial function measured by fingertip peripheral arterial tonometry from 0.52 ± 0.48 to 0.87 ± 0.29 au (P = 0.005). Chronic consumption for 4 weeks decreased central pulse pressure from 47 ± 13 to 41 ± 9 mmHg (P = 0.02) and tended to decrease carotid-femoral pulse wave velocity (P = 0.06).
- Study type
- Pilot study
- Who was studied
- 24 patients with type 2 diabetes mellitus
- What was measured
- Vascular and endothelial function, central pulse pressure, and pulse wave velocity
THE PAPER
Effects of erythritol on endothelial function in patients with type 2 diabetes mellitus: a pilot study.
Flint N, Hamburg NM, Holbrook M, Dorsey PG, LeLeiko RM, Berger A, de Cock P, Bosscher D, Vita JA. Acta Diabetol, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.